Literature DB >> 13889498

The Osgood-Schlatter lesion. A clinical and experimental study.

G EHRENBORG.   

Abstract

Keywords:  OSTEOARTHRITIS; OSTEOCHONDRITIS

Mesh：

Year:  1962        PMID： 13889498

Source DB:  PubMed          Journal:  Acta Chir Scand Suppl        ISSN： 0301-1860


× No keyword cloud information.
  8 in total

1.  Lessons learnt from managing an avulsion fracture of the tibial tubercle extending into the tibial physis.

Authors:  Rajiv Subbu; Rajpal Nandra; Robert Jordan; Steve Krikler
Journal:  BMJ Case Rep       Date:  2013-09-20

Review 2.  Treatment of Osgood-Schlatter disease: review of the literature.

Authors:  E Circi; Y Atalay; T Beyzadeoglu
Journal:  Musculoskelet Surg       Date:  2017-06-07

Review 3.  Intensive training in young athletes. The orthopaedic surgeon's viewpoint.

Authors:  N Maffulli
Journal:  Sports Med       Date:  1990-04       Impact factor: 11.136

Review 4.  Osgood-Schlatter Disease: Appearance, Diagnosis and Treatment: A Narrative Review.

Authors:  Francisco Corbi; Sergi Matas; Jesús Álvarez-Herms; Sebastian Sitko; Ernest Baiget; Joaquim Reverter-Masia; Isaac López-Laval
Journal:  Healthcare (Basel)       Date:  2022-05-30

Review 5.  Knee injuries in athletes. Review of exertion injuries and retrospective study of outpatient sports clinic material.

Authors:  U M Kujala; M Kvist; K Osterman
Journal:  Sports Med       Date:  1986 Nov-Dec       Impact factor: 11.136

6.  The sequelae of Osgood-Schlatter's disease in adults.

Authors:  J Høgh; B Lund
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075

7.  Limited ankle dorsiflexion: a predisposing factor to Morbus Osgood Schlatter?

Authors:  Zoran Sarcević
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-05-16       Impact factor: 4.342

8.  Risk assessment of the onset of Osgood-Schlatter disease using kinetic analysis of various motions in sports.

Authors:  Gento Itoh; Hideyuki Ishii; Haruyasu Kato; Yasuharu Nagano; Hiroteru Hayashi; Hiroki Funasaki
Journal:  PLoS One       Date:  2018-01-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.